Skip to main content

Galante Joseph C's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Jul 1, 2022

Accession no.
0001209191-22-040094
Filed
Jul 1, 2022
Trade date
Jun 1-30, 2022
Filing delay
30 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $3.31K. It was filed 30 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Galante Joseph CCIK 0001632384Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 1, 2022Common StockPPurchaseAcquired+76$2.05+$155.847,219Direct
Jun 2, 2022Common StockPPurchaseAcquired+76$2.08+$158.0847,295Direct
Jun 3, 2022Common StockPPurchaseAcquired+76$2.09+$158.8447,371Direct
Jun 6, 2022Common StockPPurchaseAcquired+81$2.07+$167.6747,452Direct
Jun 7, 2022Common StockPPurchaseAcquired+60$2.08+$124.847,512Direct
Jun 8, 2022Common StockPPurchaseAcquired+81$2.12+$171.7247,593Direct
Jun 9, 2022Common StockPPurchaseAcquired+81$2.09+$169.2947,674Direct
Jun 10, 2022Common StockPPurchaseAcquired+81$2.04+$165.2447,755Direct
Jun 13, 2022Common StockPPurchaseAcquired+81$2.01+$162.8147,836Direct
Jun 14, 2022Common StockPPurchaseAcquired+81$2.02+$163.6247,917Direct
Jun 15, 2022Common StockPPurchaseAcquired+81$1.98+$160.3847,998Direct
Jun 16, 2022Common StockPPurchaseAcquired+81$1.95+$157.9548,079Direct
Jun 17, 2022Common StockPPurchaseAcquired+81$1.94+$157.1448,160Direct
Jun 21, 2022Common StockPPurchaseAcquired+86$1.97+$169.4248,246Direct
Jun 22, 2022Common StockPPurchaseAcquired+82$1.99+$163.1848,328Direct
Jun 23, 2022Common StockPPurchaseAcquired+86$2.01+$172.8648,414Direct
Jun 24, 2022Common StockPPurchaseAcquired+86$2.11+$181.4648,500Direct
Jun 27, 2022Common StockPPurchaseAcquired+15$2.06+$30.948,515Direct
Jun 28, 2022Common StockPPurchaseAcquired+79$2.06+$162.7448,594Direct
Jun 29, 2022Common StockPPurchaseAcquired+86$2.11+$181.4648,680Direct
Jun 30, 2022Common StockPPurchaseAcquired+86$2.08+$178.8848,766Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)